Medicomp Systems, a provider of clinical data solutions, announced on Monday that its customer, Institut Jantung Negara (IJN), the National Heart Institute of Malaysia, has been granted Stage 7 validation by the Healthcare Information and Management Systems Society (HIMSS) Electronic Medical Record Adoption Model (EMRAM).
This is the highest level of digital health maturity recognised by HIMSS. IJN is the first hospital in Malaysia to achieve this milestone.
EMRAM Stage 7 requires hospitals to demonstrate fully paperless operations, robust data analytics capabilities, and the use of clinical data to measurably improve patient outcomes.
IJN, a 433-bed quaternary hospital and the largest integrated cardiovascular and thoracic care centre in Asia, partnered with Medicomp and its regional implementation partner APUK Co Ltd to deploy Quippe, Medicomp's evidence-based clinical documentation and decision support platform. Medicomp says that the implementation drove a rapid digital transformation, with IJN achieving 98% adoption of electronic clinical documentation. IJN had previously become the first hospital in Malaysia to achieve EMRAM Stage 6.
GE HealthCare's Photonova Spectra gains FDA clearance
Nuwellis completes Rendiatech acquisition
HeartBeam and Mount Sinai partner to advance AI-enabled cardiac monitoring
Medicomp Systems client IJN in Malaysia granted Stage 7 validation from HIMSS EMRAM
Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
Esperion to acquire Corstasis, expanding cardiovascular portfolio
Circio reports up to 50-fold gene expression gain in eye for circVec-AAV platform